This inventor holds 1 USPTO granted patent. Top assignee: Sanofi Pasteur Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: David Burt: Innovator in Immunogenic Compositions
Introduction: David Burt is an accomplished inventor based in Ajax, CA, recognized for his contributions to the field of immunogenic compositions. With a focus on respiratory viruses, his work aims to improve vaccination strategies for vulnerable populations, particularly the elderly.
Latest Patents: David Burt holds a patent for a "Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation." This innovative composition is designed to provide protection against diseases caused by respiratory syncytial virus (RSV) and influenza virus. His formulation comprises an effective mixture of purified fusion (F) protein, attachment (G) protein, and matrix (M) protein of RSV, alongside a non-virulent influenza virus preparation. Notably, when administered as a vaccine, these components maintain their immunogenicity without impairing each other, making it a promising advancement in immunization. Additionally, the composition may include an adjuvant to enhance its efficacy.
Career Highlights: David Burt's career is marked by his pivotal role at Sanofi Pasteur Inc., where he has worked diligently to advance vaccine technology. His pioneering research has not only extended his own portfolio of intellectual property but has also contributed significantly to public health.
Collaborations: Throughout his career, David has collaborated with esteemed colleagues, including George A. Cates and Suryaprakash Sambhara. These partnerships have fostered a rich collaborative environment, enabling the development of innovative solutions to address key health challenges related to respiratory viruses.
Conclusion: David Burt's contributions as an inventor have provided valuable insights into the development of immunogenic compositions that protect against respiratory diseases. With his work at Sanofi Pasteur Inc. and collaborations with prominent colleagues, he continues to make strides in enhancing public health through innovative vaccine solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile